Evidence map›Paper›PMID 30401703›Full record

ArticleBlood2019

Acute myeloid leukemia induces protumoral p16INK4a-driven senescence in the bone marrow microenvironment.

Amina M Abdul-Aziz, Yu Sun, Charlotte Hellmich, Christopher R Marlein, Jayna Mistry, Eoghan Forde, Rachel E Piddock, Manar S Shafat, Adam Morfakis, Tarang Mehta and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 102 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 2 countries.

Amina M Abdul-AzizNorwich Medical School, University of East Anglia, Norwich, United Kingdom.
Yu SunNorwich Medical School, University of East Anglia, Norwich, United Kingdom.
Charlotte HellmichNorwich Medical School, University of East Anglia, Norwich, United Kingdom.
Christopher R MarleinNorwich Medical School, University of East Anglia, Norwich, United Kingdom.
Jayna MistryNorwich Medical School, University of East Anglia, Norwich, United Kingdom.
Eoghan FordeNorwich Medical School, University of East Anglia, Norwich, United Kingdom.
Rachel E PiddockNorwich Medical School, University of East Anglia, Norwich, United Kingdom.
Manar S ShafatNorwich Medical School, University of East Anglia, Norwich, United Kingdom.
Adam MorfakisNorwich Medical School, University of East Anglia, Norwich, United Kingdom.
Tarang MehtaEarlham Institute, Norwich, United Kingdom.
Federica Di PalmaNorwich Medical School, University of East Anglia, Norwich, United Kingdom.
Iain MacaulayEarlham Institute, Norwich, United Kingdom.
Christopher J InghamDepartment of Orthopaedic and Trauma Surgery.
Anna HaestierDepartment of Obstetrics & Gynaecology, and.
Angela CollinsDepartment of Haematology, Norfolk and Norwich University Hospitals National Health Service Trust, Norwich, United Kingdom.
Judith CampisiBuck Institute for Research on Aging, Novato, CA; and.
Kristian M BowlesNorwich Medical School, University of East Anglia, Norwich, United Kingdom.
Stuart A RushworthNorwich Medical School, University of East Anglia, Norwich, United Kingdom.
University of East Anglia · GBEarlham Institute · GBBuck Institute for Research on Aging · USNorfolk and Norwich University Hospitals NHS Foundation Trust · GBOrthopaedic Trauma Association · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute myeloid leukemia (AML) is an age-related disease that is highly dependent on the bone marrow (BM) microenvironment. With increasing age, tissues accumulate senescent cells, characterized by an irreversible arrest of cell proliferation and the secretion of a set of proinflammatory cytokines, chemokines, and growth factors, collectively known as the senescence-associated secretory phenotype (SASP). Here, we report that AML blasts induce a senescent phenotype in the stromal cells within the BM microenvironment and that the BM stromal cell senescence is driven by p16INK4a expression. The p16INK4a-expressing senescent stromal cells then feed back to promote AML blast survival and proliferation via the SASP. Importantly, selective elimination of p16INK4a

Indexed as

Cellular SenescenceTumor MicroenvironmentAnimalsBone MarrowCell ProliferationCoculture TechniquesCyclin-Dependent Kinase Inhibitor p16FemaleHumansLeukemia, Myeloid, AcuteMesenchymal Stem CellsMice, Inbred C57BLNADPH Oxidase 2SuperoxidesTumor Cells, CulturedCyclin-Dependent Kinase Inhibitor p16NADPH Oxidase 2Superoxides

Identifiers

PMID30401703
PMCPMC6356984
OpenAlexW2899718571

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.